Supporting Study: Veljaca, M., et al
The same logic applies here
Treatment should be discontinued if patients have not lost at least 5% of their initial body weight after 12 weeks on the maintenance dose of 3.0 mg
Genetic-guided weight loss treatment demonstrates higher efficacy and safety margins in clinical practice, which increasingly influences how plan administrators and insurers evaluate medical necessity
Supplementary information General remarks, Supplementary Figs
We offer specialised treatments across a wide range of medical fields, including proctology, laparoscopic surgery, ENT (ear, nose, and throat), vascular, gynaecology, urology, aesthetics, orthopaedics, ophthalmology, and weight loss solutions